AKT1 and metabolic disease: Various diseases, such as metabolic disorders, neurodegenerative diseases, or physiological changes, including aging and menopause, exhibit cognitive decline as a common symptom, and many studies have reported that the PI3K/Akt signal pathway is involved in restoring the cognitive decline induced by the diseases [56,57,58].